hrcak mascot   Srce   HID

Stručni rad

Postmarketing research of the efficacy and tolerability of fluconazole and clotrimazole in the treatment of vulvovaginal Candidiasis

V. Škerk
J. Jakšić
T. Žarković
D. Škalko
J. Begovac

Puni tekst: hrvatski, pdf (62 KB) str. 135-137 preuzimanja: 626* citiraj
APA 6th Edition
Škerk, V., Jakšić, J., Žarković, T., Škalko, D. i Begovac, J. (2006). Postmarketinško ispitivanje djelotvornosti i podnošljivosti liječenja vulvovaginalne kandidoze flukonazolom i klotrimazolom. Infektološki glasnik, 26 (3), 135-137. Preuzeto s https://hrcak.srce.hr/12690
MLA 8th Edition
Škerk, V., et al. "Postmarketinško ispitivanje djelotvornosti i podnošljivosti liječenja vulvovaginalne kandidoze flukonazolom i klotrimazolom." Infektološki glasnik, vol. 26, br. 3, 2006, str. 135-137. https://hrcak.srce.hr/12690. Citirano 19.07.2019.
Chicago 17th Edition
Škerk, V., J. Jakšić, T. Žarković, D. Škalko i J. Begovac. "Postmarketinško ispitivanje djelotvornosti i podnošljivosti liječenja vulvovaginalne kandidoze flukonazolom i klotrimazolom." Infektološki glasnik 26, br. 3 (2006): 135-137. https://hrcak.srce.hr/12690
Harvard
Škerk, V., et al. (2006). 'Postmarketinško ispitivanje djelotvornosti i podnošljivosti liječenja vulvovaginalne kandidoze flukonazolom i klotrimazolom', Infektološki glasnik, 26(3), str. 135-137. Preuzeto s: https://hrcak.srce.hr/12690 (Datum pristupa: 19.07.2019.)
Vancouver
Škerk V, Jakšić J, Žarković T, Škalko D, Begovac J. Postmarketinško ispitivanje djelotvornosti i podnošljivosti liječenja vulvovaginalne kandidoze flukonazolom i klotrimazolom. Infektološki glasnik [Internet]. 2006 [pristupljeno 19.07.2019.];26(3):135-137. Dostupno na: https://hrcak.srce.hr/12690
IEEE
V. Škerk, J. Jakšić, T. Žarković, D. Škalko i J. Begovac, "Postmarketinško ispitivanje djelotvornosti i podnošljivosti liječenja vulvovaginalne kandidoze flukonazolom i klotrimazolom", Infektološki glasnik, vol.26, br. 3, str. 135-137, 2006. [Online]. Dostupno na: https://hrcak.srce.hr/12690. [Citirano: 19.07.2019.]

Sažetak
Atotal of 246 episodes of uncomplicated vulvovaginal candidiasis (VVC) were examined at gynecological outpatient primary health care departments in the period from June 1, 2006 until July 31, 2006, in patients aged 18 to 45 years in whom the symptoms lasted up to two weeks before treatment. The occurrence of VVC in 83 patients was preceded by antibiotic consumption, menstruation or taking oral contraceptives. Other patients had no predisposing factors. Sexual partners did not experience balanitis. The patients were treated according to the randomization list with either clotrimazole 1×0,2 g vaginally for 3 days or a single dose of fluconazole 1×150 mg perorally. The randomization also determined patients whose sexual partners received a single dose of fluconazole 1×150 mg perorally.
Clinical efficacy of antimicrobial treatment of uncomplicated VVC and the frequency of recurring episodes of VVC did not significantly differ with regards to the type of administered treatment or simultaneous treatment or no treatment of sexual partner.

Ključne riječi
Fluconazole; clotrimazole; vulvovaginal candidiasis

Hrčak ID: 12690

URI
https://hrcak.srce.hr/12690

[hrvatski]

Posjeta: 989 *